INSULIN DEGLUDEC / LIRAGLUTIDE (combination product) (Xultophy®)

Clinical Indication

Diabetes

Comments

Conditional on prescriber being trained to select and train patients.

Date of classification

September 2015

Review date

September 2015

Green CONDITIONAL

Drugs for which GPs are able to take full responsibility for prescribing and monitoring subject to specified conditions e.g. prescribing in line with agreed LMSG guidance or able to demonstrate suitable competence see comments under individual entries.